ASCO 2026 wasn’t just about new data—it highlighted where oncology is headed next. From breakthrough in vivo CAR-T results and RAS-targeted therapies to the growing influence of Chinese biotech on the global stage, this year’s meeting showcased the evolving future of cancer care. Listen to the recap: https://www.fiercepharma.com/pharma/behind-headlines-asco-2026
More Tips From The Bandish Group
You Never Get a Second Chance to Make a First Impression
◆
Whether you’re interviewing for your next leadership role, meeting a potential client, or networking at an industry event, first impressions…
#439: What Does a Recruiter Consider a Great Candidate?
◆
While every search is unique, recruiters typically begin by evaluating three key qualifications: When a candidate checks all three boxes,…